College of Medicine, University of Arkansas for Medical Sciences Northwest, 1125 N College Ave, Fayetteville, AR, 72703, USA.
Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
J Racial Ethn Health Disparities. 2021 Oct;8(5):1260-1266. doi: 10.1007/s40615-020-00886-5. Epub 2020 Oct 8.
Research has demonstrated that the human papillomavirus (HPV) vaccine is a safe and effective way to decrease HPV-related cervical cancers; however, the vaccination rate in the USA is suboptimal. The current study examined racial and ethnic disparities in HPV vaccination among a nationally representative sample, including Native Hawaiian and Pacific Islanders (NHPI). This study also investigated the associations between nativity and vaccination, and sex differences between race/ethnicity and vaccination and nativity and vaccination. A cross-sectional study was conducted with a sample of adults aged 18-26 years drawn from the 2014 NHPI National Health Interview Survey (n = 2590) and the general 2014 National Health Interview Survey (n = 36,697). Log-binomial models were fitted to examine differences in vaccination. There was a statistically significant racial/ethnic difference in HPV vaccination (p = 0.003). More women than men were vaccinated (41.8% vs. 10.1%) (p < 0.001). There was a significant difference in HPV vaccination based on nativity: 27.4% of adults aged 18 to 26 years who were born in the USA and 27.7% born in a US territory received the HPV vaccine compared with 14.3% among those not born in the USA or a US territory (p < 0.001). The association of HPV vaccination with nativity and race/ethnicity differed by sex and showed several nuanced differences. Overall, the prevalence of HPV vaccination was low. The study's findings demonstrate the need for public health strategies to increase vaccination rates among all populations, with the critical need to identify strategies that are effective for men, racial/ethnic minorities, and immigrant women born outside the USA.
研究表明，人乳头瘤病毒（HPV）疫苗是降低 HPV 相关宫颈癌的安全有效的方法；然而，美国的疫苗接种率并不理想。本研究在全国代表性样本中检查了 HPV 疫苗接种的种族和族裔差异，包括夏威夷原住民和太平洋岛民（NHPI）。本研究还调查了原籍国和接种疫苗之间的关联，以及种族/族裔和接种疫苗以及原籍国和接种疫苗之间的性别差异。本研究采用横断面研究设计，对来自 2014 年 NHPI 国家健康访谈调查（n=2590）和一般 2014 年全国健康访谈调查（n=36697）的 18-26 岁成年人样本进行了研究。采用对数二项式模型检验疫苗接种差异。HPV 疫苗接种存在统计学显著的种族/族裔差异（p=0.003）。女性接种疫苗的比例（41.8%）高于男性（10.1%）（p<0.001）。基于原籍国，HPV 疫苗接种存在显著差异：18-26 岁在美国出生的成年人中有 27.4%和在美国领土出生的成年人中有 27.7%接种了 HPV 疫苗，而不是在美国或美国领土出生的成年人中有 14.3%接种了 HPV 疫苗（p<0.001）。HPV 疫苗接种与原籍国和种族/族裔的关联因性别而异，表现出一些细微的差异。总体而言，HPV 疫苗接种的流行率较低。研究结果表明，需要制定公共卫生策略来提高所有人群的疫苗接种率，迫切需要确定对男性、少数族裔和出生于美国境外的移民妇女有效的策略。
